In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
Revenues | 27.1 | 27.0 | 25.4 | 20.7 | 16.5 | 14.3 | 15.6 | 13.6 |
Revenue growth | 0.5% | 6.1% | 22.7% | 25.8% | 14.9% | -7.8% | 14.4% | |
Cost of goods sold [+] | 10.4 | 10.8 | 7.9 | 6.1 | 4.9 | 3.8 | 4.1 | 3.2 |
Cost of product sales | | | 3.9 | 3.8 | 3.2 | 2.6 | 2.8 | 1.9 |
Occupancy costs | 1.3 | 1.1 | 1.1 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 |
Reimbursable costs | | | 1.5 | 0.7 | 0.7 | 0.4 | 0.5 | 0.4 |
Gross profit | 16.7 | 16.2 | 17.5 | 14.6 | 11.6 | 10.5 | 11.5 | 10.4 |
Gross margin | 61.5% | 60.0% | 68.9% | 70.6% | 70.5% | 73.4% | 73.7% | 76.6% |
Selling, general and administrative [+] | 17.1 | 16.1 | 14.0 | 12.5 | 12.0 | 9.9 | 9.5 | 9.2 |
Sales and marketing | 1.7 | 1.4 | 12.8 | 12.1 | 11.6 | 9.6 | 9.3 | 8.8 |
General and administrative [+] | 15.4 | 14.7 | 1.1 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 |
Wages and related expenses | 14.1 | 13.2 | 11.4 | 10.6 | 10.4 | 8.8 | 8.3 | 7.8 |
Professional fees | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 |
Other selling, general and administrative | 1.7 | 1.4 | 12.8 | 12.1 | 11.6 | 9.6 | 9.3 | 8.8 |
Research and development | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Other operating expenses | -3.2 | -3.6 | -0.8 | 0.1 | 1.3 | 0.9 | -5.0 | 0.9 |
EBITDA [+] | 3.4 | 3.9 | 4.5 | 2.1 | -1.6 | -0.2 | 7.3 | 1.0 |
EBITDA growth | -15.0% | -13.1% | 116.7% | -232.9% | 558.9% | -103.3% | 607.3% | |
EBITDA margin | 12.4% | 14.6% | 17.8% | 10.1% | -9.6% | -1.7% | 47.0% | 7.6% |
Depreciation and amortization | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 |
EBITA | 3.0 | 3.6 | 4.2 | 1.9 | -1.8 | -0.5 | 6.9 | 0.6 |
EBITA margin | 10.9% | 13.4% | 16.6% | 9.0% | -11.0% | -3.3% | 44.6% | 4.1% |
Amortization of intangibles | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.5 |
EBIT [+] | 2.6 | 3.6 | 4.2 | 1.8 | -1.9 | -0.5 | 6.7 | 0.1 |
EBIT growth | -27.0% | -14.6% | 130.7% | -198.0% | 289.0% | -107.1% | 6759.5% | |
EBIT margin | 9.6% | 13.3% | 16.5% | 8.8% | -11.3% | -3.3% | 43.1% | 0.7% |
Non-recurring items [+] | 0.1 | 0.0 | 0.0 | 0.6 | | | 6.1 | 0.7 |
Asset impairment | 0.1 | | | 0.5 | | | | |
Loss (gain) on sale of assets | | | | | | | 0.0 | |
Interest expense, net [+] | -0.5 | -0.5 | -0.5 | -2.1 | -2.2 | -2.2 | -2.0 | -0.6 |
Interest expense | -0.5 | -0.5 | -0.5 | -2.1 | -2.2 | -2.2 | -2.0 | -0.6 |
Interest income | | | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other income (expense), net [+] | 1.1 | -1.1 | -4.6 | -0.8 | -4.8 | -4.8 | -10.4 | -3.6 |
Gain (loss) on foreign currency transactions | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 |
Other | | | | -0.1 | | | | |
Pre-tax income | 4.2 | 3.0 | 0.1 | 2.6 | -4.5 | -3.1 | -7.8 | -3.5 |
Income taxes | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 |
Tax rate | 11.7% | 0.0% | 1.0% | | 0.4% | | | 0.0% |
Net income | 3.7 | 3.0 | 0.1 | 2.4 | -4.7 | -3.4 | -8.1 | -3.7 |
Net margin | 13.6% | 11.0% | 0.4% | 11.6% | -28.3% | -23.5% | -51.8% | -27.4% |
|
Basic EPS [+] | $0.02 | $0.02 | $0.00 | $0.02 | ($0.05) | ($0.04) | ($0.09) | ($0.04) |
Growth | 21.8% | 2773.1% | -97.2% | -148.4% | 34.4% | -58.9% | 115.8% | |
Diluted EPS [+] | $0.02 | $0.02 | $0.00 | $0.02 | ($0.05) | ($0.04) | ($0.09) | ($0.04) |
Growth | 11.9% | 2772.8% | -96.7% | -141.2% | 34.4% | -58.9% | 115.8% | |
|
Shares outstanding (basic) [+] | 150.8 | 147.9 | 145.9 | 96.6 | 90.7 | 88.0 | 86.5 | 86.3 |
Growth | 2.0% | 1.4% | 50.9% | 6.6% | 3.1% | 1.7% | 0.2% | 0.9% |
Shares outstanding (diluted) [+] | 164.6 | 148.2 | 146.2 | 113.5 | 90.7 | 88.0 | 86.5 | 86.3 |
Growth | 11.1% | 1.4% | 28.7% | 25.2% | 3.1% | 1.7% | 0.2% | 0.9% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |